| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Krzysztof W Pankiewicz | |
| Liqiang Chen | |||
| P433 | issue | 4 | |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 403-412 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Current Opinion in Drug Discovery and Development | Q15724606 |
| P1476 | title | Recent development of IMP dehydrogenase inhibitors for the treatment of cancer | |
| P478 | volume | 10 |
| Q28475058 | A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase |
| Q36740744 | A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments |
| Q33689986 | Analyzing the regulation of metabolic pathways in human breast cancer |
| Q42764570 | Control of nucleotide biosynthesis by the MYC oncoprotein |
| Q34109631 | Crystallization and preliminary X-ray analysis of mycophenolic acid-resistant and mycophenolic acid-sensitive forms of IMP dehydrogenase from the human fungal pathogen Cryptococcus |
| Q34802622 | Developing urinary metabolomic signatures as early bladder cancer diagnostic markers |
| Q53701648 | Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis. |
| Q92353570 | IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma |
| Q24642299 | IMP dehydrogenase: structure, mechanism, and inhibition |
| Q33481705 | Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis |
| Q38762107 | Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell lines |
| Q39685717 | Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. |
| Q28550069 | Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds |
| Q33618935 | One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy |
| Q33680898 | Overexpression of Inosine 5′-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells |
| Q59329785 | Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening |
| Q39205536 | Reviving the guardian of the genome: Small molecule activators of p53. |
| Q36791988 | Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase |
| Q46322657 | Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets |
| Q37983899 | The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes |
| Q33442825 | The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells |
| Q35945831 | The raspberry Gene Is Involved in the Regulation of the Cellular Immune Response in Drosophila melanogaster |
| Q34404155 | The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress |
| Q33604996 | Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase |
| Q28486568 | Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis |
| Q28543579 | Two classes of bacterial IMPDHs according to their quaternary structures and catalytic properties |
Search more.